Mount Yale Investment Advisors, LLC Sage Therapeutics, Inc. Transaction History

Mount Yale Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $819 - $1,397	-10 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$138.11 - $169.04 $12,153 - $14,875	-88 Reduced 89.8%	10 $1,000
Q2 2018 Aug 22, 2018	SELL	$140.36 - $175.76 $13,334 - $16,697	-95 Reduced 49.22%	98 $15,000
Q1 2018 Jun 25, 2018	BUY	$152.15 - $192.33 $29,364 - $37,119	193 New	193 $31,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.